What is AptarGroup's pharma — revenue?

AptarGroup (ATR) reported pharma — revenue of $438.91M in Q1 2026.

How has AptarGroup's pharma — revenue changed year-over-year?

AptarGroup's pharma — revenue increased by 7.1% year-over-year, from $409.7M to $438.91M.

What does pharma — revenue mean?

The gross income generated by the Pharma segment from its core business activities, including the sale of dispensing systems and related services. This metric provides a top-line view of the segment's scale and market relevance within the global healthcare supply chain.

AptarGroup ATR Pharma — Revenue

Discontinued — last reported Q1 '26

Similar metrics at other companies

PFEBiopharma — Revenues:

$14.16B+5.4%

VRTXPharmaceuticals — Product revenues, net

$2.99B+7.8%

PFEProduct — Revenue

$11.72B+3.7%

BAXPharmaceuticals — Net Sales

$621M+6.9%

CVSPharmacy — Revenues from external customers

$56.94B+8.4%

LHBiopharma Laboratory Services — Revenue

$780.6M+8.2%

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AptarGroup's pharma — revenue?: AptarGroup (ATR) reported pharma — revenue of $438.91M in Q1 2026.
How has AptarGroup's pharma — revenue changed year-over-year?: AptarGroup's pharma — revenue increased by 7.1% year-over-year, from $409.7M to $438.91M.
What does pharma — revenue mean?: The gross income generated by the Pharma segment from its core business activities, including the sale of dispensing systems and related services. This metric provides a top-line view of the segment's scale and market relevance within the global healthcare supply chain.